Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAMKV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
BCAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC645321 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ITGAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDHR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00161 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESRRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTKN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERICH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on